Revenue: The sum of all revenue fields included for a company's operating activities.
Ironwood Pharmaceuticals, Inc. (IRWD) had Revenue of $85.24M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
Revenue |
$85.24M |
$23.60M |
|
-- |
|
$85.24M |
|
$39.92M |
|
$45.32M |
|
$-7.50M |
|
$37.82M |
|
$37.82M |
|
$23.60M |
|
$23.60M |
|
$23.60M |
|
$23.60M |
|
$45.32M |
|
$45.79M |
|
161.72M |
|
176.84M |
|
$0.15 |
|
$0.14 |
|
Balance Sheet Financials | |
$191.75M |
|
$3.93M |
|
$151.19M |
|
$342.95M |
|
$232.53M |
|
$385.00M |
|
$418.58M |
|
$651.11M |
|
$-308.16M |
|
$-310.62M |
|
$-308.16M |
|
162.43M |
|
Cash Flow Statement Financials | |
$4.89M |
|
$-0.03M |
|
$0.09M |
|
$88.56M |
|
$92.85M |
|
$4.29M |
|
$9.81M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
5.01 |
|
-1.25 |
|
100.00% |
|
53.17% |
|
53.17% |
|
-- |
|
44.37% |
|
27.69% |
|
$4.85M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
-- |
|
0.99 |
|
90.99 |
|
-7.66% |
|
-7.60% |
|
6.88% |
|
30.71% |
|
$-1.90 |
|
$0.03 |
|
$0.03 |